SectorPharmaceutical
Established Date--
Listing Date19/11/2015
ExchangeNASDAQ Stock Exchange
Full-time Employees925
Fiscal Year Ends31/12
Security TypeCommon stock
Office address22 Cortlandt Street, 16th Floor, New York, New York 10007
Business
IntroductionAxsome Therapeutics, Inc., was founded in January 2012. The company is a clinical-stage biopharmaceutical company developing novel treatments for pain and other central nervous system or central nervous system, disease management. By focusing on this therapeutic area, they are addressing a significant and growing market where current therapeutic options are limited or insufficient. Their goal is to become a fully integrated biopharmaceutical company to develop and commercialize extended treatment options for healthcare professionals to improve life differentiation therapy for patients with pain and other CNS diseases.
